LifeGuide

Stronger Punch? Monoclonal antibodies provide new hope for easier dosing by Jeannie Wraight With multi-drug, once-a-day therapies now available for use, the push for additional easier to...

A not-for-profit biotech helps energize the future of TB vaccine R&D by Chael Needle According to the World Health Organization, tuberculosis is the most common illness...

Finger on the Pulse The UFO Plan meets young IV drug users where they are by Larry Buhl Hepatitis prevention and treatment efforts depend on outreach. For...

Not So Complicated Alisson Sombredero, MD, offers to physicians compelling approaches to HIV care by Chael Needle Alisson Sombredero, MD, is more than two months into her...

Six drugs promise to further revolutionize HCV treatments by Larry Buhl The hepatitis C (HCV) treatment revolution is a little more than a year old, but...

HCV advocate, author & nurse Lucinda Porter offers perspectives on care by Larry Buhl Lucinda Porter, RN, understands viral hepatitis from both sides: as a healthcare practitioner and...

Natasha Travis, MD, helps shape the HIV learning curve for physicians and patients by Chael Needle Awarded a 2012 Minority Clinical Fellowship by the HIV Medicine...

HCV funding and support for vulnerable populations lag far behind HIV by Larry Buhl A study published in the July/August 2012 issue of Public Health Reports...

A new study reports on the drug-drug interaction between pitavastatin and a common PI combo by Chael Needle Last year, A&U reported on a study that...

CDC Recommends Hepatitis C Testing for All Boomers by Larry Buhl For years CDC guidelines called for hepatitis C (HCV) testing when someone has known risk factors,...